PUBLISHER: The Business Research Company | PRODUCT CODE: 2077003
PUBLISHER: The Business Research Company | PRODUCT CODE: 2077003
Cell culture media and single-use reagents are specialized formulations and disposable materials developed to support the growth, maintenance, and processing of cells under controlled conditions. These include nutrient-enriched media, buffers, supplements, and pre-sterilized single-use components that ensure consistency, sterility, and operational efficiency in biological processes. They play a vital role in enabling scalable, contamination-free, and reproducible workflows in laboratory and biomanufacturing operations.
The primary cell types of cell culture media and single-use reagents include mammalian cells, stem cells, insect cells, microbial cells, and plant cells. Mammalian cells refer to widely utilized cell systems in bioprocessing that support complex protein expression and biologics production. These technologies are based on single-use bioprocessing systems, continuous bioprocessing, upstream processing technologies, and downstream processing technologies. They are categorized by portability and scale such as fully automated benchtop systems, portable and handheld analyzers, and fully integrated core-lab systems and the various applications involved are biopharmaceutical production, vaccine manufacturing, gene therapy, cell therapy, and cell culture research.
Tariffs are influencing the cell culture media and single-use reagents market by increasing the cost of imported raw materials, sterile consumables, and bioprocessing components crucial for biologics manufacturing and cell-based research. This is disrupting supply chains associated with single-use systems, media formulations, and filtration products, leading to extended procurement cycles and increased operational expenses. Regions such as Asia-Pacific and Latin America, which depend heavily on imported bioprocess inputs, are experiencing delays in the expansion of biopharmaceutical production and research capacity. However, tariffs are also driving localized manufacturing, supplier diversification, and increased investments in domestic production ecosystems, enhancing long-term supply chain resilience and self-sufficiency within the market.
The cell culture media and single-use reagents market research report is one of a series of new reports from The Business Research Company that provides cell culture media and single-use reagents market statistics, including cell culture media and single-use reagents industry global market size, regional shares, competitors with a cell culture media and single-use reagents market share, detailed cell culture media and single-use reagents market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture media and single-use reagents industry. This cell culture media and single-use reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell culture media and single-use reagents market size has grown rapidly in recent years. It will grow from $4.41 billion in 2025 to $5 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to rising adoption of serum-based cell culture systems, limited availability of standardized gmp-grade reagents, dependence on reusable laboratory consumables, fragmented global bioprocessing supply chains, early-stage adoption of single-use technologies.
The cell culture media and single-use reagents market size is expected to see rapid growth in the next few years. It will grow to $8.34 billion by 2030 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to shift toward serum-free and chemically defined media, expansion of large-scale biomanufacturing facilities, increasing adoption of single-use bioprocessing systems, growing demand for cell and gene therapy production, rising investment in automated and high-throughput cell culture platforms. Major trends in the forecast period include serum-free and chemically defined media adoption, expansion of single-use bioprocessing systems, increasing demand for contamination-free aseptic processing, rise in high-throughput cell culture screening platforms, growing emphasis on regulatory-compliant gmp-grade reagents.
The growing investment in cell and gene therapy development is expected to propel the growth of the cell culture media and single-use reagents market going forward. Cell and gene therapy development involves the process of creating treatments that modify or replace defective genes or utilize engineered cells to treat or prevent diseases. The rising investment in cell and gene therapy development is increasing due to the growing prevalence of genetic and rare diseases. The cell culture media and single-use reagents market is supported by the expanding investment in cell and gene therapy development, as these products are essential for scalable, sterile, and efficient manufacturing of advanced therapies. For instance, in September 2024, according to CGT Catapult, a UK-based independent innovation and technology organization, total investment in advanced therapies (including cell and gene therapy) reached £0.77 billion in 2023 and £0.97 billion in 2024, reflecting 26% year-on-year growth. Therefore, the growing investment in cell and gene therapy development is driving the growth of the cell culture media and single-use reagents market.
Leading companies operating in the cell culture media and single-use reagents market are focusing on single-use bioprocessing technologies, such as integrated single-use bioreactor systems, to improve production efficiency and reduce contamination risks in biomanufacturing. Integrated single-use bioreactor systems are pre-sterilized, disposable cultivation platforms that combine process control, monitoring, and fluid management into a single unit to eliminate cleaning requirements, reduce turnaround time, and ensure consistent batch performance. For example, in August 2023, Sartorius AG, a Germany-based life sciences company, and Repligen Corporation, a US-based life sciences company, launched an integrated Biostat STR system with XCell ATF technology. The system includes embedded cell retention technology and predefined control recipes, which improve process intensification and reduce setup complexity. It also enables faster installation and an optimized equipment footprint, lowering operational costs and enhancing scalability in commercial cell culture production.
In August 2024, Merck KGaA, a Germany-based healthcare technology company, acquired Mirus Bio for $600 million. Through this acquisition, Merck KGaA seeks to strengthen its cell culture and gene delivery portfolio by enhancing capabilities in transfection reagents, thereby supporting advanced biologics, vaccine development, and cell and gene therapy workflows. Mirus Bio is a US-based healthcare technology company with strong expertise in transfection reagents used to deliver genetic material into cells, a critical process in cell culture and biopharmaceutical manufacturing.
Major companies operating in the cell culture media and single-use reagents market are Thermo Fisher Scientific Inc., Merck KGaA, Fujifilm Wako, Corning Incorporated, Lonza Group AG, Avantor Inc., Agilent Technologies, Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, STEMCELL Technologies, Miltenyi Biotec, LGC Science Group Holdings Ltd, Takara Bio Inc., MP Biomedicals LLC, Chemglass Life Sciences, ATCC, ITW Reagents, PromoCell GmbH, Axol Bioscience Ltd, HiMedia Laboratories, Eppendorf AG, Kohjin Bio Co. Ltd., Nucleus Biologics, OPM Biosciences, Plant Cell Technology, ZenBio Inc., Yocon Corporation.
North America was the largest region in the cell culture media and single-use reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell culture media and single-use reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cell culture media and single-use reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell culture media and single-use reagents market consists of sales of basal cell culture media, serum and serum-free media, buffer solutions, growth factors, cytokines, single-use bioprocessing bags, disposable bioreactor liners, filtration units, tubing assemblies, and single-use mixing and storage systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Culture Media And Single-Use Reagents Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cell culture media and single-use reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cell culture media and single-use reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell culture media and single-use reagents market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.